Retatrutide × Prime Lab Peptides - Lab Test, February 2026
Test results
About this test
This independent HPLC analysis with UV detection coupled to mass spectrometry confirms Retatrutide 12mg from Prime Lab Peptides at 99.63% purity. The analysis was conducted by Freedom Diagnostics Testing on February 3, 2026, with the sample received February 2, 2026.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.63% indicates minimal contamination and high-grade synthesis.
The tested quantity of 15.30mg exceeds the stated label quantity of 12mg. The product appears as a white lyophilized powder. Mass identification confirms GLP-RT (Retatrutide) at 99.63% purity. The full certificate of analysis is available for download with accession number 2602020155.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.